The neuropathology and biochemistry of frontotemporal dementia
2003; Wiley; Volume: 54; Issue: S5 Linguagem: Inglês
10.1002/ana.10571
ISSN1531-8249
AutoresDavid G. Muñoz, Dennis W. Dickson, Catherine Bergeron, Ian R. Mackenzie, André Delacourte, Victoria Zhukareva,
Tópico(s)Dementia and Cognitive Impairment Research
ResumoAnnals of NeurologyVolume 54, Issue S5 p. S24-S28 Conference Proceedings The neuropathology and biochemistry of frontotemporal dementia David G. Munoz MD, FRCPC, Corresponding Author David G. Munoz MD, FRCPC [email protected] Departments of Pathology and Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada, and Banco de Tejidos para Investigacion Neurologica, Universidad Autonoma, Madrid, SpainBanco de Tejidos para Investigación Neurológica pabellón 3, sotano, Faculta O de Medicina, Auda. Complutense s/h 28040, Madrid, SpainSearch for more papers by this authorDennis W. Dickson MD, Dennis W. Dickson MD Department of Pathology, Mayo Clinic, Jacksonville, FLSearch for more papers by this authorCatherine Bergeron MD, FRCPC, Catherine Bergeron MD, FRCPC Department of Laboratory Medicine and Pathobiology, Centre for Research in Neurodegenerative Diseases, University of Toronto, and Department of Pathology (Neuropathology), TorontoWestern Hospital, Toronto, CanadaSearch for more papers by this authorIan R. A. Mackenzie MD, FRCPC, Ian R. A. Mackenzie MD, FRCPC Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, CanadaSearch for more papers by this authorAndre Delacourte MD, Andre Delacourte MD Inserm U422, Lille, FranceSearch for more papers by this authorVictoria Zhukareva PhD, Victoria Zhukareva PhD Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PASearch for more papers by this author David G. Munoz MD, FRCPC, Corresponding Author David G. Munoz MD, FRCPC [email protected] Departments of Pathology and Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada, and Banco de Tejidos para Investigacion Neurologica, Universidad Autonoma, Madrid, SpainBanco de Tejidos para Investigación Neurológica pabellón 3, sotano, Faculta O de Medicina, Auda. Complutense s/h 28040, Madrid, SpainSearch for more papers by this authorDennis W. Dickson MD, Dennis W. Dickson MD Department of Pathology, Mayo Clinic, Jacksonville, FLSearch for more papers by this authorCatherine Bergeron MD, FRCPC, Catherine Bergeron MD, FRCPC Department of Laboratory Medicine and Pathobiology, Centre for Research in Neurodegenerative Diseases, University of Toronto, and Department of Pathology (Neuropathology), TorontoWestern Hospital, Toronto, CanadaSearch for more papers by this authorIan R. A. Mackenzie MD, FRCPC, Ian R. A. Mackenzie MD, FRCPC Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, CanadaSearch for more papers by this authorAndre Delacourte MD, Andre Delacourte MD Inserm U422, Lille, FranceSearch for more papers by this authorVictoria Zhukareva PhD, Victoria Zhukareva PhD Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PASearch for more papers by this author First published: 23 June 2003 https://doi.org/10.1002/ana.10571Citations: 66Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 1803–1809. 2 Kertesz A, Munoz DG. Pick's disease and Pick complex. New York: Wiley-Liss, 1998. 3 Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001; 49: 165–175. 4 Munoz DG. The pathology of Pick complex. In: A Kertesz, DG Munoz, eds. Pick's disease and Pick complex. New York: Wiley-Liss, 1998: 211–241. 5 Zhukareva V, Mann D, Pickering-Brown S, et al. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter. Ann Neurol 2002; 51: 730–739. 6 Forman MS, Zhukareva V, Bergeron C, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 2002; 160: 2045–2053. 7 Zhukareva V, Mann D, Pickering-Brown S, et al. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter. Ann Neurol 2002; 51: 730–739. 8 Munoz-Garcia D, Ludwin SK. Classic and generalized variants of Pick's disease: a clinicopathological, ultrastructural, and immunocytochemical comparative study. Ann Neurol 1984; 16: 467–480. 9 Probst A, Tolnay M, Langui D, et al. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol 1996; 92: 588–596. 10 Delacourte A, Robitaille Y, Sergeant N, et al. Specific pathological tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996; 55: 159–168. 11 Delacourte A, Sergeant N, Wattez A, et al. Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol 1998; 43: 193–204. 12 Yasuhara O, Aimi Y, McGeer EG, McGeer PL. Accumulation of amyloid precursor protein in brain lesions of patients with Pick disease. Neurosci Lett 1994; 171: 63–66. 13 Yasuhara O, Matsuo A, Tooyama I, et al. Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons. Acta Neuropathol 1995; 89: 322–330. 14 Braak H, Braak E. Pick's disease: cytoskeletal changes in the hypothalamic lateral tuberal nucleus. Brain Res 1998; 802: 119–124. 15 Braak E, Arai K, Braak H. Cerebellar involvement in Pick's disease: affliction of mossy fibers, monodendritic brush cells, and dentate projection neurons. Exp Neurol 1999; 159: 153–163. 16 Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002; 61: 935–946. 17 Mackenzie IR, Hudson LP. Achromatic neurons in the cortex of progressive supranuclear palsy. Acta Neuropathol 1995; 90: 615–619. 18 Togo T, Dickson DW. Ballooned neurons in progressive supranuclear palsy are usually due to concurrent argyrophilic grain disease. Acta Neuropathol 2002; 104: 53–56. 19 Braak H, Braak E. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol 1989; 15: 13–26. 20 Martinez-Lage P, Munoz DG. Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol 1997; 56: 157–164. 21 Togo T, Cookson N, Dickson DW. Argyrophilic grain disease: neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol 2002; 12: 45–52. 22 Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001; 56: 1702–1706. 23 Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002; 61: 547–556. 24 Kawashima T, Furuta A, Doh-ura K, et al. Ubiquitin-immunoreactive skein-like inclusions in the neostriatum are not restricted to amyotrophic lateral sclerosis, but are rather aging-related structures. Acta Neuropathol 2000; 100: 43–49. 25 Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions. Acta Neuropathol 2001; 102: 94–102. 26 Rosso SM, Kamphorst W, de Graaf B, et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21–22. Brain 2001; 124: 1948–1957. Citing Literature Volume54, IssueS5Supplement: Frontotemporal Dementia and Pick's Disease Conference Proceedings2003Pages S24-S28 ReferencesRelatedInformation
Referência(s)